HCC Trials: Insights from the LAUNCH, EMERALD-1, and LEAP-012 Trials
Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.
EP: 1.Examining the Role of Liver Function in HCC
EP: 2.HCC Staging: Improving Treatment Strategies
EP: 3.Locoregional Therapies for Intermediate-Stage HCC
Now Viewing
EP: 4.HCC Trials: Insights from the LAUNCH, EMERALD-1, and LEAP-012 Trials
EP: 5.Emerging Therapies in Intermediate-Stage HCC
EP: 6.Updates from IMbrave150, LEAP-002, and HIMALAYA Trials
EP: 7.Comorbidity Considerations for HCC Treatment
EP: 8.The Evolving Landscape of Second-Line Therapies in HCC Management
EP: 9.Additional Second-Line Treatments for HCC
EP: 10.Real-World Evidence on Second-Line Therapy Selection and Outcomes
Related Videos
Related Content
